Avoro Capital Advisors’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $169M | Sell |
|
|||||
|
2025
Q1 | $193M | Buy |
|
|||||
|
2024
Q4 | $222M | Hold |
|
|||||
|
2024
Q3 | $223M | Hold |
|
|||||
|
2024
Q2 | $221M | Hold |
|
|||||
|
2024
Q1 | $244M | Hold |
|
|||||
|
2023
Q4 | $261M | Buy |
|
|||||
|
2023
Q3 | $167M | Hold |
|
|||||
|
2023
Q2 | $189M | Hold |
|
|||||
|
2023
Q1 | $175M | Hold |
|
|||||
|
2022
Q4 | $193M | Hold |
|
|||||
|
2022
Q3 | $177M | Hold |
|
|||||
|
2022
Q2 | $149M | Sell |
|
|||||
|
2022
Q1 | $152M | Hold |
|
|||||
|
2021
Q4 | $156M | Buy |
|
|||||
|
2021
Q3 | $55.8M | Hold |
|
|||||
|
2021
Q2 | $68M | Hold |
|
|||||
|
2021
Q1 | $65.3M | Buy |
|
|||||
|
2020
Q4 | $43.1M | Hold |
|
|||||
|
2020
Q3 | $31M | Hold |
|
|||||
|
2020
Q2 | $35.1M | Buy |
|
|||||
|
2020
Q1 | $31.4M | Buy |
|
|||||
|
2019
Q4 | $31.5M | Hold |
|
|||||
|
2019
Q3 | $21.6M | Hold |
|
|||||
|
2019
Q2 | $23.7M | Hold |
|
|||||
|
2019
Q1 | $24.4M | Hold |
|
|||||
|
2018
Q4 | $15.1M | Buy |
|
|||||
|
2018
Q3 | $31.2M | Buy |
|
|||||
|
2018
Q2 | $11.1M | Buy |
|